Continuous Glucose Monitoring Devices Market - Industry Analysis by Type, Technology, End-Use, Application and Top Key Players by 2027 | Medtronic PLC, Animas Corporation, and Novo Nordisk A/S, ARKRAY, etc

According to a report by Reports and Data, the Continuous Glucose Monitoring devices market was valued at USD 3.45 Billion in 2020 and is estimated to reach USD 14.7 billion by 2027, growing at a CAGR of 19.2%. Estimating and identifying appropriate blood glucose level in patients through continuous glucose monitoring (CGM) devices is a vital component of therapy success. Continuous glucose monitoring evolved from enzyme-based electrochemical glucose sensors. It is an instrument with a small sensor attached with a transmitter for daily diabetes management. The Continuous Glucose Monitoring devices aid in better diabetes management by proactively tracking glucose level fluctuations in interstitial fluid as a basis for improving metabolic control. CGM devices help in reducing the risk of hyperglycemia & hypoglycemia.

Get a sample PDF copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/2172

The global spread of diabetes along with increasing geriatric population and continuous technological advancements have propelled the market growth of the CGM devices. According to the WHO, Diabetes is increasing at an alarming rate in the United States, and nearly 30.3 million people, or 9.4% of the U.S. population, have diabetes. An estimated 23.1 million people - or 7.2% of the population - had diagnosed diabetes. North America accounts for the largest share in the global continuous glucose monitoring devices market due to government initiatives undertaken for prevention of diabetes and treatment support along with the presence of dominant players in this region, technological advancements in the drug discovery procedures, growing rate of obesity in the region, sedentary lifestyle and techno savvy population.

The market report on the global Continuous Glucose Monitoring Devices market also includes an extensive analysis of the overall competitive scenario. The report studies the key marketing and promotional strategies that are adopted by the leading companies in the market. Furthermore, It also takes into account the existing development, historical events, and the latest trends to provide the readers a strong and unbiased opinion on the direction towards which the leading companies will be heading into in the future. The market report mentions all factors and events impacting the market, such as mergers, acquisitions, joint ventures, strategic alliances, takeovers, and others. It also studies the overall intensity of the competition prevailing in the global Continuous Glucose Monitoring Devices market.

Some of the key players mentioned in the research report are:
Dexcom
Abbott Laboratories
Pfizer Inc.
Inc. Baxter International
Menarini Diagnostics
Johnson & Johnson
Others

While, there are certain restraining factors which stand as potential challenges to the market growth. Inadequate reimbursement and high cost associated with the application of CGM devices, measurement reliability, human factors issues, lack of a standardized format for displaying results, and uncertainty pertaining to the best use of CGM data to make therapeutic decisions are some of the key factors hampering the growth of this market during the forecast period.

For the purpose of this report, Reports and Data has segmented the Continuous Glucose Monitoring devices market on the basis of component, end use, and region:

By Component (Revenue, USD Million; 2020–2027)
Insulin Pumps
Transmitters & receivers
Sensors

By End-Use (Revenue, USD Million; 2020–2027)
Hospitals
Homecare settings
Others

Get discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2172

By Region (Revenue, USD Million; 2020–2027)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Key findings from the report suggest

Insulin Pumps segment is expected to attain the highest CAGR of 15.6% due to technological developments aiding advanced diabetes care management the region where geriatric population is growing such as China and India.

Transmitters & Receivers has been the largest segment due to its critical importance in the devices. It is expected to maintain its market share dominance in the forecast period.

Based on End-use, Homecare settings segment has the largest market share due to advanced technological developments in the market and ease of use of the CGM devices; that enables the healthcare providers to provide best of the services to their patients

Several personal CGM systems are available in the United States for daily use by people with diabetes. For instance, the Abbott FreeStyle Libre flash CGM system received FDA approval in September 2017 for stand-alone use. This sensor and transmitter system requires no calibrations or fingerstick blood glucose confirmations to make diabetes treatment decisions.

North America accounts for the largest share in the global continuous glucose monitoring devices due to government initiatives undertaken for prevention of diabetes and treatment support and holds a dominant market share in 2018. It is projected to maintain its position during the forecast period with the market share of 33.7%.

Europe has trailed the North American region in terms of revenue generation due to increasing adoption of these devices by countries such as Germany, Italy, France and Spain.

High prevalence of diabetes in some of the developing countries like India & China in the Asia Pacific region, has successfully propelled the growth of the CGM devices market. It is expected to register a highest CAGR of 15.0% in the forecast period.

Get Complete Report detailed @ https://www.reportsanddata.com/report-detail/continuous-glucose-monitoring-devices-market

The increasing incidence of diabetes patients would require focus on healthcare and would directly contribute to the growth of the target market. Furthermore, the factors that lead to diabetes such as obesity, dietary deficiency, high calorie intake, high cholesterol, smoking and excessive alcohol consumption contribute to the market growth indirectly.

According to WHO, average medical expenditures for people with diagnosed diabetes were about USD13, 700 per year about USD 7,900 of this amount was attributed to diabetes. It is expected to support the demand for CGM devices and positively influence the market growth.

The Continuous Glucose Monitoring Devices Market report delivers the principle locale, latest economic situations with the item value, benefits, production capacity, demand and supply, market development rate, and others. Additionally, the report also performs SWOT examination, speculation attainability investigation, and venture return investigation.

Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.

Contact Us:

John Watson
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.